BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1287831)

  • 1. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose.
    Borowiec J; Thelin S; Bagge L; Hultman J; Hansson HE
    Scand J Thorac Cardiovasc Surg; 1992; 26(3):177-85. PubMed ID: 1287831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
    Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
    Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
    Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
    Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system.
    Scrascia G; Rotunno C; Guida P; Conte M; Amorese L; Margari V; Schinosa Lde L; Paparella D
    Interact Cardiovasc Thorac Surg; 2013 May; 16(5):636-42. PubMed ID: 23335652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coagulation, fibrinolysis, and cell activation in patients and shed mediastinal blood during coronary artery bypass grafting with a new heparin-coated surface.
    Johnell M; Elgue G; Larsson R; Larsson A; Thelin S; Siegbahn A
    J Thorac Cardiovasc Surg; 2002 Aug; 124(2):321-32. PubMed ID: 12167793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin coating of an extracorporeal circuit partly improves hemostasis after cardiopulmonary bypass.
    Boonstra PW; Gu YJ; Akkerman C; Haan J; Huyzen R; van Oeveren W
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):289-92. PubMed ID: 8283898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
    Kuitunen AH; Heikkilä LJ; Salmenperä MT
    Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery--a clinical study.
    Borowiec J; Thelin S; Bagge L; van der Linden J; Thörnö E; Hansson HE
    Ups J Med Sci; 1992; 97(1):55-66. PubMed ID: 1523735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
    Horimoto H; Kondo K; Asada K; Sasaki S
    Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC; Nuttall GA; Ereth MH; Santrach PJ; Buda DA; Schaff HV
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
    Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
    Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
    Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does heparin pretreatment affect the haemostatic system during and after cardiopulmonary bypass?
    Brinks HJ; Weerwind PW; Bogdan S; Verbruggen H; Brouwer MH
    Perfusion; 2001 Jan; 16(1):3-12. PubMed ID: 11192305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery bypass surgery with heparin-coated perfusion circuits and low-dose heparinization.
    Mullen JC; Bentley MJ; Gelfand ET; Koshal A; Modry DL; Guenther CR; Etches WS; Stang LJ; Lopushinsky SR
    Can J Surg; 2002 Jun; 45(3):166-72. PubMed ID: 12067167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig.
    Thelin S; Bagge L; Hultman J; Borowiec J; Nilsson L; Thorelius J
    Eur J Cardiothorac Surg; 1991; 5(9):486-91. PubMed ID: 1931093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets.
    Mirow N; Brinkmann T; Minami K; Tenderich G; Schulte-Eistrup S; Kleesiek K; Körfer R
    J Cardiovasc Surg (Torino); 2001 Oct; 42(5):579-85. PubMed ID: 11562580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.